NCT06693700 A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
| NCT ID | NCT06693700 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Condition | Smoking |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2024-11-14 |
| Primary Completion | 2027-11-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2024-11-14 with a primary completion date of 2027-11-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.
Eligibility Criteria
Inclusion Criteria: * Adult (aged \>18 years) MSK patients as per the EHR * Has been referred and enrolled in the MSK TTP and completed the initial counseling session as per the TTP clinical database * Reports current (within the past 30 days) tobacco use (i.e., cigarettes and/or any other tobacco products) as per the TTP Intake form * Must be English-speaking in the EHR * Must be reachable by phone as per self-report * Must have Wi-Fi available at home as per self-report Exclusion Criteria: * Patient reports that no smoking is allowed, by them or anyone else, in the home as per the TTP intake form and/or per self-report
Contact & Investigator
Gleneara Bates-Pappas, PhD, LMSW
PRINCIPAL INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Frequently Asked Questions
Who can join the NCT06693700 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06693700 currently recruiting?
Yes, NCT06693700 is actively recruiting participants. Contact the research team at batespag@mskcc.org for enrollment information.
Where is the NCT06693700 trial being conducted?
This trial is being conducted at Basking Ridge, United States, Middletown, United States, Montvale, United States, Commack, United States and 4 additional locations.
Who is sponsoring the NCT06693700 clinical trial?
NCT06693700 is sponsored by Memorial Sloan Kettering Cancer Center. The principal investigator is Gleneara Bates-Pappas, PhD, LMSW at Memorial Sloan Kettering Cancer Center. The trial plans to enroll 10 participants.